FindTrial
Sign In

Ayurvedic management for skin disease

Pharmaceutico-Analytical Study Of Gandirikadya Taila: A Clinical Evaluation Of Its Effectiveness In Dadru

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/09/036804
Enrollment
36
Registered
2021-09-24
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B354- Tinea corporis Health Condition 2: B354- Tinea corporis

Interventions

Intervention1: Gandirikadya Taila: Content and preparation of GAndirikadya Taila-1 part of katu taila 1/4th part kalka of snuhi,chitraka,Bhringraj, Arka, Kushtha,Argavadha tvaka,Saindhav lavan each in

Sponsors

Dr Akshata Sanjay Chavan
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients showing either one or more signs and symptoms of dadru (Kandu raga pidaka udgat mandala with elongated or circular patch)Patients showing minimum 2 3 or all signs and symptoms will be included

Exclusion criteria

Exclusion criteria: Any known cases of chronic uncontrolled systemic illness or Immunocompromised patients or patient on Immunosuppressive drugs and Patches spread extensively invading more than 25 percent of body surface or any other skin disease

Design outcomes

Primary

MeasureTime frame
Patient will be assessed by kandu(Itching),Raga(Redness),Number of mandala,Size of pidaka parametersTimepoint: Followup-Every patient will assessed at 0,7,14,28th day—

Secondary

MeasureTime frame
Patient will be assessed by kandu(Itching),Raga(Redness),Number of mandala,Size of pidaka parametersTimepoint: Followup-Every patient will assessed at 0,7,14,28th day—

Countries

India

Contacts

Public ContactDr Sheela Pargunde

Dr G D Pol Foundations YMTAMC

sheela.pargunde@gmail.com9324493208

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026